← Back to Search

COPD Care Transition Programs for Chronic Obstructive Pulmonary Disease (REVISITS Trial)

N/A
Recruiting
Led By Valerie Press
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 24 months post-intervention (aim 3)
Awards & highlights
No Placebo-Only Group

Summary

This trial will study two methods of delivering COPD care transition programs to see which is most effective in decreasing acute care revisits.

Who is the study for?
This trial is for US hospital sites, not individuals. It's designed to compare the effectiveness of virtual versus in-person care transition programs for patients with Chronic Obstructive Pulmonary Disease (COPD).
What is being tested?
The study tests two COPD care transition interventions: one delivered in person and the other virtually. Both are supported by mentoring, with some sites also using co-design methods to implement these programs.
What are the potential side effects?
Since this trial focuses on implementation strategies at hospital sites rather than direct patient interventions, it does not specify side effects related to medications or treatments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 24 months post-intervention (aim 3)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 24 months post-intervention (aim 3) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Delivery of overall care transition program: penetration
Sustainability of effectiveness: 30-day revisits
Sustainability of program delivery: penetration
Secondary study objectives
Cost/savings evaluation
Delivery of care transition program individual interventions: penetration
Healthcare Utilization: 30-day acute care revisits (all cause)
+18 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: Virtual intervention delivery with virtual mentoring with co-designExperimental Treatment1 Intervention
The implemented interventions will be virtual and will include virtual mentoring and co-design support with our study partner, Onda Collective. The mentored implementation model (MIM) is an evidence-based strategy to promote the success and sustainability of hospital-based quality improvement (QI) initiatives. After completing the contextual assessments and pre-implementation planning in Aim 1, the investigators will collaborate with the SHM to harness their expertise with the MIM to implement the COPD Program over a one-year period during Aim 2 (implementation). Virtual Mentored Implementation involves implementing their assigned care transition program intervention delivery method using an innovative virtual mentored implementation approach using tele-conferencing technology (i.e., video-conferences) for two-way visualization of individuals in different locations for educational purposes. Monthly mentoring sessions will occur to maximize mentors' input.
Group II: Virtual intervention delivery with virtual mentoringExperimental Treatment1 Intervention
The implemented interventions will be virtual and will include virtual mentoring. The mentored implementation model (MIM) is an evidence-based strategy to promote the success and sustainability of hospital-based quality improvement (QI) initiatives. After completing the contextual assessments and pre-implementation planning in Aim 1, the investigators will collaborate with the SHM to harness their expertise with the MIM to implement the COPD Program over a one-year period during Aim 2 (implementation). Virtual Mentored Implementation involves implementing their assigned care transition program intervention delivery method using an innovative virtual mentored implementation approach using tele-conferencing technology (i.e., video-conferences) for two-way visualization of individuals in different locations for educational purposes. Monthly mentoring sessions will occur to maximize mentors' input.
Group III: In-person intervention delivery with virtual mentoring and co-designExperimental Treatment1 Intervention
The implemented interventions will be in-person and will include virtual mentoring and co-design support with our study partner, Onda Collective. The mentored implementation model (MIM) is an evidence-based strategy to promote the success and sustainability of hospital-based quality improvement (QI) initiatives. After completing the contextual assessments and pre-implementation planning in Aim 1, the investigators will collaborate with the SHM to harness their expertise with the MIM to implement the COPD Program over a one-year period during Aim 2 (implementation). Virtual Mentored Implementation involves implementing their assigned care transition program intervention delivery method using an innovative virtual mentored implementation approach using tele-conferencing technology (i.e., video-conferences) for two-way visualization of individuals in different locations for educational purposes. Monthly mentoring sessions will occur to maximize mentors' input.
Group IV: In-person intervention delivery with virtual mentoringExperimental Treatment1 Intervention
The implemented interventions will be in-person and will include virtual mentoring. The mentored implementation model (MIM) is an evidence-based strategy to promote the success and sustainability of hospital-based quality improvement (QI) initiatives. After completing the contextual assessments and pre-implementation planning in Aim 1, the investigators will collaborate with the SHM to harness their expertise with the MIM to implement the COPD Program over a one-year period during Aim 2 (implementation). Virtual Mentored Implementation involves implementing their assigned care transition program intervention delivery method using an innovative virtual mentored implementation approach using tele-conferencing technology (i.e., video-conferences) for two-way visualization of individuals in different locations for educational purposes. Monthly mentoring sessions will occur to maximize mentors' input.

Find a Location

Who is running the clinical trial?

The Hospital Medicine Reengineering Network (HOMERuN)UNKNOWN
Onda CollectiveUNKNOWN
COPD FoundationOTHER
17 Previous Clinical Trials
238,286 Total Patients Enrolled

Media Library

COPD Transitions of Care Intervention Bundle: In-Person Interventions Clinical Trial Eligibility Overview. Trial Name: NCT05568043 — N/A
Chronic Obstructive Pulmonary Disease Research Study Groups: Virtual intervention delivery with virtual mentoring, In-person intervention delivery with virtual mentoring, In-person intervention delivery with virtual mentoring and co-design, Virtual intervention delivery with virtual mentoring with co-design
Chronic Obstructive Pulmonary Disease Clinical Trial 2023: COPD Transitions of Care Intervention Bundle: In-Person Interventions Highlights & Side Effects. Trial Name: NCT05568043 — N/A
COPD Transitions of Care Intervention Bundle: In-Person Interventions 2023 Treatment Timeline for Medical Study. Trial Name: NCT05568043 — N/A
~8 spots leftby Mar 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top